Jalal A. Aram

Also affiliated with Melinta Therapeutics (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis”.

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.01584-23

N/A

0.483DataRank · unranked

24 citations

Chris M. Pillar, Mariana Castanheira, Cecília G Carvalhaes, David R. Andes, Jalal A. Aram +7 more

Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.00549-21

N/A

0DataRank · unranked

6 citations

Lisa Long, Janet Herrada, Jalal A. Aram, Thomas S. McCormick, Mahmoud A. Ghannoum +1 more